Literature DB >> 12399076

Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy.

Ulrike Seegers1, Heidrun Potschka, Wolfgang Löscher.   

Abstract

Several recent studies have shown that the multidrug transporter P-glycoprotein (PGP) is over-expressed in endothelial cells from brain blood vessels of patients with refractory temporal lobe epilepsy (TLE), suggesting that altered drug permeability across the blood-brain barrier (BBB) may be involved in pharmacoresistance to antiepileptic drugs (AEDs). Furthermore, over-expression of PGP has been found in astrocytes of epileptogenic tissue. However, it is not known in which regions of the temporal lobe PGP over-expression occurs and whether the over-expression is a result of uncontrolled seizures, of the mechanisms underlying epilepsy, or of chronic administration of AEDs. In the present study, we used the rat kainate model of TLE to study the time-course of PGP expression in capillary endothelium and parenchyma of the hippocampus and several other limbic brain regions thought to be involved in TLE. Kainate was administered at a dose which produced a generalized convulsive status epilepticus (SE), which was limited to a duration of 90 min by diazepam. PGP was detected by immunohistochemistry either 24 h or 10 days after SE, using a monoclonal PGP antibody. In both kainate-treated rats and controls, PGP staining was observed mainly in microvessel endothelial cells and, to a much lesser extent, in parenchymal cells. Twenty-four hours after SE, significant increases in PGP expression were determined in endothelial cells of the dentate gyrus and in parenchymal cells of the CA1 and CA3 sectors of the hippocampus. Furthermore, increased PGP expression was observed in the amygdala, piriform, and parietal cortex, but not in the substantia nigra. Ten days after the kainate-induced SE, except for an increase in parenchymal PGP expression in the dentate hilus and CA1 sector, no significant differences to controls were determined, indicating that most PGP increases seen 24 h after SE were only transient. The data indicate that PGP over-expression is a transient result of seizures and occurs in several regions of the temporal lobe. Seizure-induced over-expression of PGP in capillary endothelial cells of the BBB is likely to reduce the penetration of AEDs into brain parenchyma, which could explain the drug-refractoriness of seizures in TLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399076     DOI: 10.1016/s0920-1211(02)00156-0

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

Review 1.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

2.  Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy.

Authors:  J Schlichtiger; A Pekcec; H Bartmann; P Winter; C Fuest; J Soerensen; H Potschka
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.

Authors:  Stina Syvänen; Maarten Schenke; Dirk-Jan van den Berg; Rob A Voskuyl; Elizabeth C de Lange
Journal:  AAPS J       Date:  2012-01-04       Impact factor: 4.009

Review 4.  Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy.

Authors:  Hadas Han; Aniv Mann; Dana Ekstein; Sara Eyal
Journal:  AAPS J       Date:  2017-05-26       Impact factor: 4.009

5.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

6.  Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.

Authors:  Alberto Lazarowski; Alberto Javier Ramos; Hernán García-Rivello; Alicia Brusco; Elena Girardi
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

7.  Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization.

Authors:  Alberto Javier Ramos; Alberto Lazarowski; Marcelo J Villar; Alicia Brusco
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

8.  HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.

Authors:  Yan Chen; Xian-Jing Huang; Nian Yu; Yuan Xie; Kang Zhang; Fang Wen; Hao Liu; Qing Di
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

9.  P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.

Authors:  Aimei Ma; Cuicui Wang; Yinghui Chen; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-12-03       Impact factor: 4.162

10.  The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.

Authors:  Joost Westerhout; Jean Smeets; Meindert Danhof; Elizabeth C M de Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-29       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.